Page 266 - Tata_Chemicals_yearly-reports-2021-22
P. 266

Integrated Annual Report 2021-22





              Consolidated Statement of Changes in Equity for the year ended March 31, 2022
                      ` in crore   254.82    254.82   ` in crore  Non-  controlling   interests   763.77    179.85    0.70    180.55    -      (91.72)   -      852.60    147.51    (0.32)   147.19    0.28    (95.57)   904.50


                                      attributable    12,642.84    256.37    1,415.66    1,672.03    -      (280.23)   0.51    14,035.15    1,257.62    2,959.78    4,217.40    0.28    (254.76)   17,998.07   General Counsel & Company Secretary
                                    Total   Foreign   to the equity   currency   shareholders   translation   of the parent  reserve   2,062.55    -      (181.63)   (181.63)   -      -      -      1,880.92    -      133.33    133.33    -      -      2,014.25   Chairman  Director  Managing Director and CEO  Chief Financial Officer




                                    Items of other comprehensive income  Effective   portion of   cash flow   hedges   (281.63)   1,568.02    -      -      282.43    1,221.72    282.43    1,221.72    -      1.51    -      -      -      -      0.80    2,791.25    -      -      837.30    1,630.84    837.30    1,630.84    -      -      -      -      838.10    4,422.09   For and on behalf of the Board   Nandakumar S. Tirumalai












                                  Other Equity  Equity instruments   through other   Retained   comprehensive   earnings*  income   6,185.80    256.37    93.14    349.51    (1.51)   (280.23)   0.51    6,254.08    1,257.62    358.31    1,615.93    0.28    (254.76)   7,615.53   N. Chandrasekaran   (DIN: 00121863)  Padmini Khare Kaicker  (DIN: 00296388)   R. Mukundan   (DIN: 00778253)  (ICAI M. No.: 203896)   Rajiv Chandan   (ICSI M. No.: FCS 4312)





                                         General   reserve  1,522.47    -      -      -     -   -      -     1,522.47    -      -      -      -      -     1,522.47

                                                0.10    -      -      -      -      -      -      0.10    -      -      -      -      -      0.10
                                    Reserves and surplus  Capital   Securities   redemption   premium  reserve   1,258.89    -      -      -      -      -      -      1,258.89    -      -      -      -      -      1,258.89
                               Other equity (note 17) and non-controlling interests (note 18)






                                       Capital reserve   and other   reserves from   amalgamation   326.64    -      -      -      -      -      -      326.64    -      -      -      -      -      326.64  *  Includes balance of remeasurement of net loss on defined benefit plans  of ` 282.64 crore (2021: ` 640.95 crore).









                   Equity share capital (note 16)  Balance as at March 31, 2022 Balance as at March 31, 2021   Other comprehensive income (net of tax)   Total comprehensive income for the year   Transfer to retained earnings - sale of non-current investment    Joint venture Reserve movement    Other comprehensive income (net of tax)   Total comprehensive income  for the year   Change due to dissolution of subsidiary    Notes 1 to 50 are integral part of these Consolid
















                   a.   Particulars  b.   Particulars   Balance as at April 1, 2020    Profit for the year    Dividends     Balance as at March 31, 2021    Profit for the year    Dividends     Balance as at March 31, 2022   For B S R & Co. LLP  Chartered Accountants  Vijay Mathur   Partner   Membership No. 046476  Mumbai, April 29, 2022


           264
   261   262   263   264   265   266   267   268   269   270   271